BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 35711410)

  • 1. Contribution of
    Motta-Raymundo A; Rosmaninho P; Santos DF; Ferreira RD; Silva SP; Ferreira C; Sousa AE; Silva SL
    Front Immunol; 2022; 13():834137. PubMed ID: 35711410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric Cancer Is the Leading Cause of Death in Italian Adult Patients With Common Variable Immunodeficiency.
    Pulvirenti F; Pecoraro A; Cinetto F; Milito C; Valente M; Santangeli E; Crescenzi L; Rizzo F; Tabolli S; Spadaro G; Agostini C; Quinti I
    Front Immunol; 2018; 9():2546. PubMed ID: 30455695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Dysfunctional Immune System in Common Variable Immunodeficiency Increases the Susceptibility to Gastric Cancer.
    Gullo I; Costa C; Silva SL; Ferreira C; Motta A; Silva SP; Ferreira RD; Rosmaninho P; Faria E; Costa JTD; Câmara R; Gonçalves G; Santos-Antunes J; Oliveira C; Machado JC; Carneiro F; Sousa AE
    Cells; 2020 Jun; 9(6):. PubMed ID: 32575504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric Cancer Screening in Common Variable Immunodeficiency.
    van der Poorten DK; McLeod D; Ahlenstiel G; Read S; Kwok A; Santhakumar C; Bassan M; Culican S; Campbell D; Wong SWJ; Evans L; Jideh B; Kane A; Katelaris CH; Keat K; Ko Y; Lee JA; Limaye S; Lin MW; Murad A; Rafferty M; Suan D; Swaminathan S; Riminton SD; Toong C; Berglund LJ
    J Clin Immunol; 2018 Oct; 38(7):768-777. PubMed ID: 30219982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric pathology in patients with common variable immunodeficiency.
    Zullo A; Romiti A; Rinaldi V; Vecchione A; Tomao S; Aiuti F; Frati L; Luzi G
    Gut; 1999 Jul; 45(1):77-81. PubMed ID: 10369708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decline of gastric cancer mortality in common variable immunodeficiency in the years 2018-2022.
    Milito C; Pulvirenti F; Garzi G; Sculco E; Cinetto F; Firinu D; Lagnese G; Punziano A; Discardi C; Costanzo G; Felice C; Spadaro G; Ferrari S; Quinti I
    Front Immunol; 2023; 14():1231242. PubMed ID: 37868983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burden of disease from Helicobacter pylori infection in western Canadian Arctic communities.
    Fagan-Garcia K; Geary J; Chang HJ; McAlpine L; Walker E; Colquhoun A; van Zanten SV; Girgis S; Archie B; Hanley B; Corriveau A; Morse J; Munday R; Goodman KJ;
    BMC Public Health; 2019 Jun; 19(1):730. PubMed ID: 31185961
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Lucero Y; Oyarzún A; O'Ryan M; Quera R; Espinosa N; Valenzuela R; Simian D; Alcalde E; Arce C; Farfán MJ; Vergara AF; Gajardo I; Mendez J; Carrasco J; Errázuriz G; Gonzalez M; Ossa JC; Maiza E; Perez-Bravo F; Castro M; Araya M
    Front Cell Infect Microbiol; 2017; 7():376. PubMed ID: 28879170
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationship of Helicobacter pylori eradication with gastric cancer and gastric mucosal histological changes: a 10-year follow-up study.
    Zhou L; Lin S; Ding S; Huang X; Jin Z; Cui R; Meng L; Li Y; Zhang L; Guo C; Xue Y; Yan X; Zhang J
    Chin Med J (Engl); 2014; 127(8):1454-8. PubMed ID: 24762588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [CD4+ and CD8+ T cells in gastric mucosa in children infected with Helicobacter pylori].
    Li ZY; Chen FB; Chen J
    Zhonghua Er Ke Za Zhi; 2005 Jun; 43(6):453-6. PubMed ID: 16053734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoprevention of gastric cancer by Helicobacter pylori eradication and its underlying mechanism.
    Kim N
    J Gastroenterol Hepatol; 2019 Aug; 34(8):1287-1295. PubMed ID: 30828872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of Primary and Metachronous Gastric Cancers Discovered after
    Maehata Y; Nakamura S; Esaki M; Ikeda F; Moriyama T; Hida R; Washio E; Umeno J; Hirahashi M; Kitazono T; Matsumoto T
    Gut Liver; 2017 Sep; 11(5):628-634. PubMed ID: 28395508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum bactericidal activity against Helicobacter pylori in patients with hypogammaglobulinaemia.
    Desar IM; van Deuren M; Sprong T; Jansen JB; Namavar F; Vandenbroucke-Grauls CM; van der Meer JW
    Clin Exp Immunol; 2009 Jun; 156(3):434-9. PubMed ID: 19438595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes of gastric mucosa histopathology after Helicobacter pylori eradication].
    Zhou LY; Shen ZY; Lin SR; Jin Z; Ding SG; Huang XB; Xia ZW; Liu JJ; Guo HL; William C
    Zhonghua Nei Ke Za Zhi; 2003 Mar; 42(3):162-4. PubMed ID: 12816696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic factors in the development of gastric precancerous lesions--a role of Helicobacter pylori ?
    Jablonská M; Chlumská A
    J Physiol Paris; 2001; 95(1-6):477-81. PubMed ID: 11595478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori infection in gastric cancerogenesis.
    Konturek PC; Konturek SJ; Brzozowski T
    J Physiol Pharmacol; 2009 Sep; 60(3):3-21. PubMed ID: 19826177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic severe mucosal atrophy indicates the presence of gastric cancer after Helicobacter pylori eradication -analysis based on the Kyoto classification.
    Ohno A; Miyoshi J; Kato A; Miyamoto N; Yatagai T; Hada Y; Kusuhara M; Jimbo Y; Ida Y; Tokunaga K; Okamoto S; Hisamatsu T
    BMC Gastroenterol; 2020 Jul; 20(1):232. PubMed ID: 32689949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the differences in structural chromosomal aberrations of the gastric mucosa between H. pylori positive and negative gastric cancer patients: involvement of H. pylori in the onset of gastric cancer and examination of the mechanism in gastric carcinogenesis following H. pylori eradication.
    Ohara T; Kasanuki J; Ohara H; Kanoh Y; Suzuki H; Hashimoto H; Chiba T; Morishita T; Hibi T
    Oncol Rep; 2006 Dec; 16(6):1333-42. PubMed ID: 17089058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric colonisation with a restricted commensal microbiota replicates the promotion of neoplastic lesions by diverse intestinal microbiota in the Helicobacter pylori INS-GAS mouse model of gastric carcinogenesis.
    Lertpiriyapong K; Whary MT; Muthupalani S; Lofgren JL; Gamazon ER; Feng Y; Ge Z; Wang TC; Fox JG
    Gut; 2014 Jan; 63(1):54-63. PubMed ID: 23812323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple eradication therapy counteracts functional impairment associated with Helicobacter pylori infection in Mongolian gerbils.
    Brzozowski T; Konturek PC; Kwiecien S; Konturek SJ; Pajdo R; Drozdowicz D; Ptak A; Pawlik M; Stachura J; Pawlik WW; Hahn EG
    J Physiol Pharmacol; 2003 Mar; 54(1):33-51. PubMed ID: 12674217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.